| CD70, a novel target of CAR T-cell therapy for gliomas L Jin, H Ge, Y Long, C Yang, Y Chang, L Mu, EJ Sayour, G De Leon, ... Neuro-oncology 20 (1), 55-65, 2018 | 161 | 2018 |
| Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma LB Hoang‐Minh, FA Siebzehnrubl, C Yang, S Suzuki‐Hatano, K Dajac, ... The EMBO journal 37 (23), e98772, 2018 | 134 | 2018 |
| Differential immune microenvironments and response to immune checkpoint blockade among molecular subtypes of murine medulloblastoma CD Pham, C Flores, C Yang, EM Pinheiro, JH Yearley, EJ Sayour, Y Pei, ... Clinical Cancer Research 22 (3), 582-595, 2016 | 107 | 2016 |
| Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM H Ge, L Mu, L Jin, C Yang, Y Chang, Y Long, G DeLeon, L Deleyrolle, ... International Journal of Cancer 141 (7), 1434-1444, 2017 | 78 | 2017 |
| The IDH1 mutation-induced oncometabolite, 2-hydroxyglutarate, may affect DNA methylation and expression of PD-L1 in gliomas L Mu, Y Long, C Yang, L Jin, H Tao, H Ge, YE Chang, A Karachi, ... Frontiers in molecular neuroscience 11, 82, 2018 | 77 | 2018 |
| Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition A Karachi, C Yang, F Dastmalchi, EJ Sayour, J Huang, H Azari, Y Long, ... Neuro-oncology 21 (6), 730-741, 2019 | 74 | 2019 |
| Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging AJ Grippin, B Wummer, T Wildes, K Dyson, V Trivedi, C Yang, ... ACS nano 13 (12), 13884-13898, 2019 | 70 | 2019 |
| CD4+ and perivascular Foxp3+ T cells in glioma correlate with angiogenesis and tumor progression L Mu, C Yang, Q Gao, Y Long, H Ge, G DeLeon, L Jin, Y Chang, ... Frontiers in immunology 8, 1451, 2017 | 49 | 2017 |
| Analysis of immunobiologic markers in primary and recurrent glioblastoma M Rahman, J Kresak, C Yang, J Huang, W Hiser, P Kubilis, D Mitchell Journal of neuro-oncology 137, 249-257, 2018 | 47 | 2018 |
| Immune escape after adoptive T-cell therapy for malignant gliomas TJ Wildes, KA Dyson, C Francis, B Wummer, C Yang, O Yegorov, D Shin, ... Clinical Cancer Research 26 (21), 5689-5700, 2020 | 28 | 2020 |
| Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling F Dastmalchi, A Karachi, C Yang, H Azari, EJ Sayour, A Dechkovskaia, ... Journal for Immunotherapy of Cancer 7, 1-13, 2019 | 23 | 2019 |
| RNA-modified T cells mediate effective delivery of immunomodulatory cytokines to brain tumors F Pohl-Guimarães, C Yang, KA Dyson, TJ Wildes, J Drake, J Huang, ... Molecular Therapy 27 (4), 837-849, 2019 | 22 | 2019 |
| Long-term outcome of epilepsy surgery: A retrospective study in a population of 379 cases S Yu, Z Lin, L Liu, S Pu, H Wang, J Wang, C Xie, C Yang, M Li, H Shen Epilepsy research 108 (3), 555-564, 2014 | 22 | 2014 |
| Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy C Flores, T Wildes, BDV Dean, G Moore, J Drake, R Abraham, J Gil, ... Science advances 5 (11), eaav9879, 2019 | 20 | 2019 |
| Optimizing T cell-based therapy for glioblastoma A Karachi, F Dastmalchi, S Nazarian, J Huang, EJ Sayour, L Jin, C Yang, ... Frontiers in immunology 12, 705580, 2021 | 10 | 2021 |
| Slow-cycling cells in glioblastoma: a specific population in the cellular mosaic of cancer stem cells C Yang, G Tian, M Dajac, A Doty, S Wang, JH Lee, M Rahman, J Huang, ... Cancers 14 (5), 1126, 2022 | 9 | 2022 |
| Effects of immune checkpoint blockade on antigen‐specific CD8+ T cells for use in adoptive cellular therapy E Ogando‐Rivas, P Castillo, N Jones, V Trivedi, J Drake, A Dechkovskaia, ... Microbiology and Immunology 66 (5), 201-211, 2022 | 6 | 2022 |
| ATIM-15. Sustained complete radiographic response and prolonged systemic immune activation in a patient with MGMT unmethylated midline glioblastoma receiving CMV pp65-LAMP RNA … M Rahman, A Ghiaseddin, O Yegorov, C Yang, A Dechkovskaia, D Tran, ... Neuro-oncology 21 (Supplement_6), vi4-vi4, 2019 | 3 | 2019 |
| CD70 as a critical mediator of tumor progression and immunosuppression in gliomas. C Yang, H Ge, L Jin, QJ Wang, JC Yang, Y Long, Y Chang, J Drake, L Mu, ... Journal of clinical oncology 35 (7_suppl), 18-18, 2017 | 2 | 2017 |
| mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors V Trivedi, C Yang, K Klippel, O Yegorov, C von Roemeling, L Hoang-Minh, ... Genome Medicine 16 (1), 17, 2024 | 1 | 2024 |
